Belharra

Curated by Signal

Provider of photoaffinity-based chemoproteomics platform  for drug discovery

Overview

Provider of photoaffinity-based chemoproteomics platform  for drug discovery. It offers an integrated chemoproteomic-based drug discovery engine to explore protein-ligand interactions in the cell. It is developing drugs for oncology, immuno-oncology, autoimmune and neurodegenerative diseases.

Key facts

Founded: 2021
Headquarters: San Diego, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Primary office: Sign up to view
Phone: Sign up to view

Open roles

1 role

Research Assistant, Compound Management
San Diego, CA · On-site · Volunteer

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Agilisium
Services related to the implementation and support for cloud infrastructure
Life Sciences TechnologyLos Angeles, United States
Aethon
Autonomous robots for internal logistics in hospitals
Life Sciences TechnologyPittsburgh, United States
Basepaws
Provider of genetic testing for cats
Life Sciences TechnologyMountain View, United States

About Belharra

What does Belharra do?

Provider of photoaffinity-based chemoproteomics platform  for drug discovery.

Where is Belharra headquartered?

Belharra is headquartered in San Diego, United States.

When was Belharra founded?

Belharra was founded in 2021.

Which sector is Belharra in?

Belharra operates in Life Sciences Technology.

Who are Belharra's competitors?

Companies similar to Belharra include Agilisium, Aethon, and Basepaws.

Is Belharra hiring?

Yes. Belharra has 1 open role listed on Vanberra Signal.